Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients

Hallmarks of Cancer: New Dimensions

(2022) Douglas Hanahan   Cancer Discovery

Role of the runt‐related transcription factor (RUNX) family in prostate cancer

(2021) Hannah Ashe et al.   FEBS Journal

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

(2021) András Lánczky et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer

(2021) Rahul Aggarwal et al.   JAMA Oncology

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

(2020) Louis Buscail et al.   Nature Reviews Gastroenterology & Hepatology

Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses

(2020) Jesse M. Jaynes et al.   Science Translational Medicine

TIMER2.0 for analysis of tumor-infiltrating immune cells

(2020) Taiwen Li et al.   NUCLEIC ACIDS RESEARCH

An update on vitamin D signaling and cancer

(2020) Carsten Carlberg et al.   SEMINARS IN CANCER BIOLOGY

miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1

(2020) Dapeng Zhang et al.   Cancer Cell International

CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma

(2020) Mohammad Awaji et al.   FASEB JOURNAL

Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future

(2020) Iris Z. Uras et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer

(2020) Oksana V. Maksymchuk et al.   Pharmacological Reports

Cancer health disparities in racial/ethnic minorities in the United States

(2020) Valentina A. Zavala et al.   BRITISH JOURNAL OF CANCER

KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition

(2019) Helen Adderley et al.   EBioMedicine

A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges

(2019) Indu Kohaar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis

(2019) Lechen Li et al.   ONCOGENE

KRAS -Mutant Non-Small Cell Lung Cancer: From Biology to Therapy

(2018) Irene Ferrer et al.   LUNG CANCER

iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data

(2018) Steven Xijin Ge et al.   BMC BIOINFORMATICS

Prostate Cancer–Specific Mortality Across Gleason Scores in Black vs Nonblack Men

(2018) Brandon A. Mahal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma

(2017) Jonas Cicenas et al.   MEDICAL ONCOLOGY

KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer

(2017) Andrew M. Waters et al.   Cold Spring Harbor Perspectives in Medicine

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

(2017) Shuang G. Zhao et al.   JAMA Oncology

Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome

(2016) S. You et al.   CANCER RESEARCH

Identification of Keratin 19–Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using 18 F-Fluorodeoxyglucose Positron Emission Tomography

(2016) Takayuki Kawai et al.   CLINICAL CANCER RESEARCH

Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers

(2016) Aaron M. Chapman et al.   LUNG CANCER

CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer

(2016) H Zhang et al.   ONCOGENE

Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

(2016) Felix Royo et al.   Oncotarget

The Molecular Taxonomy of Primary Prostate Cancer

(2015) Adam Abeshouse et al.   CELL

Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer

(2015) J.-G. Zhu et al.   Clinical & Translational Oncology

Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma

(2015) T. Kawai et al.   CLINICAL CANCER RESEARCH

African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men

(2015) Kosj Yamoah et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Keratin 19 expression correlates with poor prognosis in breast cancer

(2014) Nuzhat N. Kabir et al.   MOLECULAR BIOLOGY REPORTS

Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer

(2014) Irfan A. Asangani et al.   NATURE

Gene expression signatures of primary and metastatic uterine leiomyosarcoma

(2013) Ben Davidson et al.   HUMAN PATHOLOGY

African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?

(2013) Debasish Sundi et al.   JOURNAL OF CLINICAL ONCOLOGY

Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity

(2013) Zhu A. Wang et al.   NATURE CELL BIOLOGY

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

(2013) T Karantanos et al.   ONCOGENE

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Active Surveillance for Low-risk Prostate Cancer in African American Men: A Multi-institutional Experience

(2013) Brian D. Odom et al.   UROLOGY

STAR: ultrafast universal RNA-seq aligner

(2012) Alexander Dobin et al.   BIOINFORMATICS

Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

(2012) M R Abern et al.   PROSTATE CANCER AND PROSTATIC DISEASES

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis

(2011) Haeryoung Kim et al.   HEPATOLOGY

Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val

(2010) Veda N. Giri et al.   BJU INTERNATIONAL

An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression

(2010) Jindan Yu et al.   CANCER CELL

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient

(2010) Yates   INTERNATIONAL JOURNAL OF ONCOLOGY

Keratins in health and cancer: more than mere epithelial cell markers

(2010) V Karantza   ONCOGENE

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients

(2010) Cristina Magi-Galluzzi et al.   PROSTATE

Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer

(2009) Dorothea Weckermann et al.   JOURNAL OF CLINICAL ONCOLOGY

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH